ArticleCase reports in oncology

A Rare Case of Hemolytic Anemia after Alectinib That Did Not Recur after Switching to Lorlatinib.

X Tonnar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.